# Hyperfine, Inc. Reports First Quarter 2026 Financial Results
Canonical URL: https://biopharmsignal.com/news/HYPR/hyperfine-inc-reports-first-quarter-2026-financial-results
Ticker: HYPR
Company: Hyperfine
Source: Hyperfine
Published: 2026-05-12 20:05 EST
Original Source URL: https://investors.hyperfine.io
## Summary

GUILFORD, Conn. --(BUSINESS WIRE)--May 12, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter

## Article Body
GUILFORD, Conn. --(BUSINESS WIRE)--May 12, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter
## Recent Company News
- 2026-05-26 12:15 EST — [Hyperfine to Join Russell 2000® and Russell 3000® Indexes](https://biopharmsignal.com/news/HYPR/hyperfine-to-join-russell-2000r-and-russell-3000r-indexes) — Source: Hyperfine
- 2026-05-22 12:15 EST — [Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments](https://biopharmsignal.com/news/HYPR/hyperfine-announces-presentation-of-results-from-the-prime-study-showing-portable-mri-substantially-reduces-time-to-imaging-in-emergency-departments) — Source: Hyperfine
- 2026-05-12 20:05 EST — [Hyperfine, Inc. Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/HYPR/hyperfine-inc-reports-first-quarter-2026-financial-results) — Source: Hyperfine
- 2026-05-06 20:05 EST — [Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/HYPR/hyperfine-inc-to-participate-in-upcoming-2026-jefferies-global-healthcare-conference) — Source: Hyperfine
- 2026-04-29 12:15 EST — [Hyperfine Swoop® System Introduced as India’s First Portable MRI for Bedside Brain Imaging at the Country’s Leading Medical Institution](https://biopharmsignal.com/news/HYPR/hyperfine-swoopr-system-introduced-as-india-s-first-portable-mri-for-bedside-brain-imaging-at-the-country-s-leading-medical-institution) — Source: Hyperfine
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)